WNK3 and breast neoplasm: These exciting results suggest that a cohort of “PR-negative” breast tumors assigned using standard clinical IHC protocols in fact express significantly high levels of phospho-Ser294 PR target gene mRNA transcripts whose collective expression (i.e., the activated PR transcriptome) signifies the presence of activated phospho-Ser294 PRs.